CTI BioPharma Corp (CTIC) is higher by Friday morning, with the stock adding 2.91% in pre-market trading to 4.95. CTIC's short-term technical score of 94 indicates that the stock has traded more bullishly over the last month than 94% of stocks on the market. In the Biotechnology industry, which ranks 136 out of 146 industries, CTIC ranks higher than 99% of stocks. CTI BioPharma Corp has risen 11.34% over the past month, closing at $5.23 on March 25. During this period of time, the stock fell as low as $4.24 and as high as $5.25. CTIC has an average analyst recommendation of Strong Buy. The company has an average price target of $7.48.
CTIC has an Overall Score of 80. Find out what this means to you and get the rest of the rankings on CTIC!